IMMUNOGENICITY AND SAFETY OF A TRIVALENT SUBUNIT IMMUNOADJUVANT INFLUENZA VACCINE IN CHILDREN WITH TYPE 1 DIABETES: RESULTS OF A PROSPECTIVE COMPARATIVE STUDY

by Аlla A. Tarasova, Еlena V. Кolbasina, Еlena F. Lukushkina, Yury G. Kuzmichev, Mikhail P. Kostinov
Published 2016-11-01